Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Pre-Close Trading Statement

23 Jan 2020 07:00

RNS Number : 6544A
Computacenter PLC
23 January 2020
 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

FOR IMMEDIATE RELEASE

Computacenter plc

Pre-Close Trading Update - 23 January 2020

Computacenter plc ("Computacenter" or the "Group"), a leading independent technology partner trusted by large corporate and public sector organisations, today publishes a trading update, based on preliminary unaudited financial information, for the year ended 31 December 2019 ("the year").

Overview

We very much look forward to the announcement of our full year results for 2019 on Thursday 12 March 2020 as they will show that 2019 has been one of the most successful years in Computacenter's history. Not only have we recorded our best ever revenue, profit, earnings per share and cash generation from ongoing operations, but we have increased our profitability by the largest absolute amount ever. Having recently upgraded our full year guidance again in our unscheduled Trading Update on 10 December 2019, the Board remains comfortable with the upper end of current market expectations1 for the 2019 financial year.

Financial Performance

Total revenue for the Group grew by 16 per cent and by 17 per cent in constant currency. Excluding the effect of recent acquisitions, particularly the US and the Netherlands businesses purchased in 2018, organic revenue grew by 3 per cent and by 4 per cent in constant currency.

 UK

Overall reported UK revenue has been broadly flat with some low margin deals being reported on an agency basis under IFR15 which contributed to an increase in Technology Sourcing gross margin. The total adjusted gross profit contribution in the UK was a record performance with strong margin growth in both our Technology Sourcing and Services businesses.

Germany

Despite the well-publicised industrial slow-down in Germany and the substantial slow-down during 2019 from our largest customer in 2018, where we maintained our market share, we saw continued good growth in Germany particularly aided by the performance of both existing and new public sector customers.

France

France built on the performance we have seen over the last few years, with strong growth from our large customers and a material increase in our customer base as we have increased sales capacity, which bodes well for the future.

While much work is to be done to broaden the offering and strengthen the business still further, 2019 saw France deliver its largest ever profit contribution to the Group.

International

The Netherlands has contributed to the profitability of the Group. In future we will be able to develop the business more effectively now that it has been fully integrated onto the Group's ERP system and into the management structures from 1 November 2019.

Both Switzerland and Belgium have performed in line with our expectations.

USA

After 15 months of ownership, we remain pleased with our acquisition in the US and the on-going integration into the Group. While the financial performance in the first half of 2019 was somewhat disappointing as previously announced, we have recovered strongly in the second half. However, it is important to point out the nature of the business acquired is slightly more volatile than the Group as a whole and until we have fully integrated and expanded the offering in the US, this will remain so.

Financial Position

At the end of the year, Group cash and cash equivalents were ahead of the Board's expectations. We were extremely pleased with both the cash generation during the year and the closing cash and cash equivalents position and note the strong performance from our Finance Shared Service Centre cash collection teams.

During the second half of the year, helped by the strong cash performance, we paid down £30 million of the Group's debt facility, earlier than planned, which was taken out to finance the FusionStorm acquisition in the US, leaving a balance of £56 million drawn under the facility.

Group Outlook

The results of 2019 set a high bar for the business as we go into 2020. However, we go into the year with confidence, helped by the strong momentum within the Group and the broader market. We have multiple growth drivers. Geographically, we have expanded our footprint; technologically, we continue to develop our capability in areas such as Networking, Security and Cloud; and in Services, as we continue our long-term investment in the development of our portfolio of propositions.

As we continue to grow Computacenter on multiple fronts, it is obviously not without risk, but we believe our opportunities are vast.

We look forward to publishing our final results for the year ended 31 December 2019 on Thursday 12 March 2020.

Enquiries:

Computacenter plc

Mike Norris, Chief Executive

+44 (0) 1707 631 601

Tony Conophy, Finance Director

+44 (0) 1707 631 515

Tulchan Communications

James Macey White / Matt Low

+44 (0) 2073 534 200

Conference Call:

There will be a conference call for analysts and investors this morning at 08:30. For dial-in details, please contact Yasemin Balman at Tulchan Communications at Computacenter@tulchangroup.com

1 Market expectations for the year ended 31 December 2019 are assessed as at 13 January 2020 as being £140.8 million of adjusted profit before tax within a range of £136 million to £143 million. Market expectations are assessed by the Group as the average of the consensus indications given by the investment analysts that regularly provide guidance and analysis on the Group's future performance to the market.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBTMPTMTATBTM
Date   Source Headline
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding
15th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.